These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes. Bednarek-Jędrzejek M, Kwiatkowski S, Ksel-Hryciów J, Tousty P, Nurek K, Kwiatkowska E, Cymbaluk-Płoska A, Torbé A. J Perinat Med; 2019 Sep 25; 47(7):732-740. PubMed ID: 31339858 [Abstract] [Full Text] [Related]
47. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy. Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Peguero A, Dominguez C, Gratacos E. Fetal Diagn Ther; 2014 Feb 25; 35(4):258-66. PubMed ID: 24714555 [Abstract] [Full Text] [Related]
52. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Stepan H, Galindo A, Hund M, Schlembach D, Sillman J, Surbek D, Vatish M. Ultrasound Obstet Gynecol; 2023 Feb 25; 61(2):168-180. PubMed ID: 35816445 [Abstract] [Full Text] [Related]
53. Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation. Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH. Fetal Diagn Ther; 2014 Feb 25; 35(4):240-8. PubMed ID: 24853452 [Abstract] [Full Text] [Related]
54. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Conroy AL, McDonald CR, Gamble JL, Olwoch P, Natureeba P, Cohan D, Kamya MR, Havlir DV, Dorsey G, Kain KC. Am J Obstet Gynecol; 2017 Dec 25; 217(6):684.e1-684.e17. PubMed ID: 29031892 [Abstract] [Full Text] [Related]
55. Does a sFlt-1/PlGF ratio result > 655 before 34 weeks' gestation necessitate preterm delivery within 2 days? A retrospective observational study. Siepen C, Brennecke S. J Matern Fetal Neonatal Med; 2024 Dec 25; 37(1):2371047. PubMed ID: 38926094 [Abstract] [Full Text] [Related]
56. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. Myers JE, Kenny LC, McCowan LM, Chan EH, Dekker GA, Poston L, Simpson NA, North RA, SCOPE consortium. BJOG; 2013 Sep 25; 120(10):1215-23. PubMed ID: 23906160 [Abstract] [Full Text] [Related]
57. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction. Herraiz I, Quezada MS, Rodriguez-Calvo J, Gómez-Montes E, Villalaín C, Galindo A. Ultrasound Obstet Gynecol; 2018 Nov 25; 52(5):631-638. PubMed ID: 28876491 [Abstract] [Full Text] [Related]
58. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia. Akolekar R, de Cruz J, Foidart JM, Munaut C, Nicolaides KH. Prenat Diagn; 2010 Mar 25; 30(3):191-7. PubMed ID: 20101671 [Abstract] [Full Text] [Related]
59. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia. Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, Escribano D, Denk B, Galindo A. Ultrasound Obstet Gynecol; 2014 May 25; 43(5):525-32. PubMed ID: 24185845 [Abstract] [Full Text] [Related]
60. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women. Hanita O, Alia NN, Zaleha AM, Nor Azlin MI. Malays J Pathol; 2014 Apr 25; 36(1):19-26. PubMed ID: 24763231 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]